Multicultural Healthy Diet to Reduce Cognitive Decline
MHD
4 other identifiers
interventional
393
1 country
1
Brief Summary
This is a pilot randomized controlled clinical trial is designed to investigate whether the Multicultural Healthy Diet (MHD), an anti-Inflammatory diet tailored to a multi-cultural population, can improve cognitive functioning in a middle aged (40-65 yr) urban population in Bronx, New York compared to a usual diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2017
CompletedFirst Posted
Study publicly available on registry
August 7, 2017
CompletedStudy Start
First participant enrolled
October 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2023
CompletedResults Posted
Study results publicly available
December 12, 2024
CompletedDecember 12, 2024
December 1, 2024
4.8 years
August 1, 2017
July 3, 2024
December 10, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Mean Global Composite Cognition Score From Baseline
Change in global composite cognition score (standardized unit) is computed as the average of the three domain-specific Z-scores of the participant's performance on three ambulatory cognitive assessments: visuospatial working memory (Dot Grid Memory), processing speed (Symbol Search), and short-term associative memory binding (Color Shapes Task) at 9 months post baseline (Burst 1). Z-scores are centered at a population mean of "0" (i.e., a Z-score of "0" signifies that the data point(s) is equal to the population mean at study baseline for all three tasks in the composite average; positive Z-score group values indicate the number of standard deviations the data point(s) is above the mean and negative Z-score group values indicate the number of standard deviations the data point(s) is below the mean). Mean change in global composite Z-score from baseline will be reported by study arm. Increase in composite Z-scores from baseline are associated with improved cognition.
Baseline (Burst 1) and 9 months (Burst 2)
Secondary Outcomes (40)
Dietary Inflammatory Index (DII) Score
Baseline (Burst 1) and 9 months (Burst 2)
Energy-Adjusted DII Score
Baseline (Burst 1) and 9 months (Burst 2)
Total Serum Folate Levels
Baseline (Burst 1) and 9 months (Burst 2)
α-Tocopherol Levels
Baseline (Burst 1) and 9 months (Burst 2)
α-Carotenoid Levels
Baseline (Burst 1) and 9 months (Burst 2)
- +35 more secondary outcomes
Study Arms (2)
Anti-inflammatory dietary intervention
ACTIVE COMPARATOR18 month intervention of dietary counseling to adhere to the Multicultural Healthy Diet or the anti-inflammatory diet,
Usual Diet plus Self-Care
PLACEBO COMPARATOR18 month intervention of usual diet plus self-care modules
Interventions
An anti-inflammatory dietary pattern consists of a dietary pattern that has high anti-inflammatory potential
Usual diet plus sessions that focus on self-care such as dealing with aches and pains of aging.
Eligibility Criteria
You may qualify if:
- living, working, attending school or visiting Co-op City, Bronx (e.g. for shopping, doctors' visits, etc.) or communities neighboring Co-op City and between 40-65 yr of age
- willingness to accept assignment to intervention or comparison diet group
- willingness to participate in a study where weight loss is not a primary goal
You may not qualify if:
- cognitively impaired
- history of traumatic brain injury
- psychiatric illness
- history of diabetes and experiencing hypoglycemia
- liver disease
- uncontrolled hypertension as defined as blood pressure \> 140/90 mm Hg
- history of cardiovascular disease that affects physical functioning
- severe chronic illness
- low literacy
- history of alcohol or drug dependence
- hematologic disease or malignancy not in remission for more than 5 years
- visual, auditory, or motor impairment that precludes cognitive testing.
- chronic kidney disease on dialysis or special diet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Albert Einstein College of Medicinelead
- Penn State Universitycollaborator
- Kaiser Permanentecollaborator
- University of Minnesotacollaborator
- National Institute on Aging (NIA)collaborator
- National Center for Advancing Translational Sciences (NCATS)collaborator
Study Sites (1)
Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
Related Publications (3)
Mossavar-Rahmani Y, Shaw PA, Hakun JG, Katz MJ, Wylie-Rosett J, Sliwinski MJ. Multicultural Healthy Diet to Reduce Cognitive Decline & Alzheimer's Disease Risk: Study protocol for a pilot randomized controlled trial. Contemp Clin Trials. 2023 Jan;124:107006. doi: 10.1016/j.cct.2022.107006. Epub 2022 Nov 14.
PMID: 36396064BACKGROUNDMossavar-Rahmani Y, Hyun N, Hakun JG, Katz MJ, Pavlovic JM, Zetterberg H, Wang Z, Yang JB, Wylie-Rosett J, Hebert JR, Sliwinski MJ, Shaw PA. The effects of the Multicultural Healthy Diet on cognitive decline and Alzheimer's disease risk: a phase II randomized controlled trial in middle-aged adults. Am J Clin Nutr. 2025 Jul;122(1):48-59. doi: 10.1016/j.ajcnut.2025.05.011. Epub 2025 May 22.
PMID: 40412481DERIVEDHakun JG, Benson L, Qiu T, Elbich DB, Katz M, Shaw PA, Sliwinski MJ, Mossavar-Rahmani Y. Cognitive Health Benefits of Everyday Physical Activity in a Diverse Sample of Middle-Aged Adults. Ann Behav Med. 2025 Jan 4;59(1):kaae059. doi: 10.1093/abm/kaae059.
PMID: 39427230DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Yasmin Mossavar-Rahmani
- Organization
- Albert Einstein College of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Yasmin Mossavar-Rahmani, Ph.D, RD
Albert Einstein College of Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The research clinician who assesses cognitive status needs to be blinded to assignment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Epidemiology & Population Health
Study Record Dates
First Submitted
August 1, 2017
First Posted
August 7, 2017
Study Start
October 2, 2018
Primary Completion
July 3, 2023
Study Completion
August 30, 2023
Last Updated
December 12, 2024
Results First Posted
December 12, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Reasonable time after completion of data analysis and key manuscripts
- Access Criteria
- Data and specimens will be shared with potential collaborators, after obtaining participant consent, consistent with HIPPA guidelines.
Data and specimens will be shared with potential collaborators, after obtaining participant consent, consistent with HIPPA guidelines